The Food and Drug Administration has revealed that the maker of a brand of eye drops linked to an outbreak of fatal bacterial infections failed to follow multiple safety protocols.

The FDA visited a Global Pharma Healthcare facility in India for an inspection in mid-February and found dozens of issues ranging from dirty equipment and clothing to missing safeguards and procedures.

The inspection came two-and-a-half weeks after the company voluntarily recalled the EzriCare artificial tears product because of possible contamination.

When the recall was issued, there were already 55 reports of adverse events, including eye infections, permanent loss of vision, and at least one death from a bloodstream infection.

Share:
More In Business
Taylor Swift Movie Sparks Debate About Etiquette at Theaters
Taylor Swift's concert tour has dominated the box office in recent days and it's also the top-grossing concert film of all time here in the U.S. But a conversation on social media raised questions about movie etiquette and videos shared show film audiences singing, shining their phone flashlights and dancing in the aisles.
Stocks Fall Amid Renewed Fears Over Rate Hikes
Stocks fell at the open Tuesday as the 10-year Treasury yield spiked following retail sales data and bank earnings, raising concerns over more rate hikes. Investors are also keeping an eye on tensions in the Middle East and its potential effect on global markets.
Load More